PGAP6
Basic information
Region (hg38): 16:370788-387113
Previous symbols: [ "TMEM6", "TMEM8", "TMEM8A" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PGAP6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 82 | 91 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 82 | 10 | 0 |
Variants in PGAP6
This is a list of pathogenic ClinVar variants found in the PGAP6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-372012-C-G | not specified | Uncertain significance (May 18, 2022) | ||
16-372016-C-A | not specified | Uncertain significance (Sep 03, 2024) | ||
16-372054-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
16-372062-C-G | not specified | Uncertain significance (Apr 17, 2024) | ||
16-372067-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
16-372075-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
16-372085-G-T | Likely benign (May 01, 2023) | |||
16-372128-C-G | not specified | Uncertain significance (Oct 25, 2024) | ||
16-372150-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
16-372151-A-G | not specified | Uncertain significance (Dec 15, 2022) | ||
16-372184-C-T | not specified | Likely benign (May 22, 2024) | ||
16-372187-T-A | not specified | Uncertain significance (Jun 11, 2021) | ||
16-372202-T-C | not specified | Uncertain significance (Jul 06, 2021) | ||
16-372208-C-T | not specified | Likely benign (Jan 26, 2022) | ||
16-372211-C-T | not specified | Uncertain significance (Sep 09, 2021) | ||
16-372261-C-T | not specified | Uncertain significance (Feb 03, 2022) | ||
16-372271-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
16-372614-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
16-372624-A-T | not specified | Uncertain significance (Jan 29, 2024) | ||
16-372627-A-C | not specified | Uncertain significance (Jan 29, 2024) | ||
16-372649-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
16-372675-C-T | not specified | Uncertain significance (May 21, 2024) | ||
16-372694-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
16-374024-A-T | not specified | Uncertain significance (May 24, 2023) | ||
16-374028-G-A | not specified | Uncertain significance (May 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PGAP6 | protein_coding | protein_coding | ENST00000431232 | 13 | 16341 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.37e-10 | 0.940 | 125402 | 0 | 154 | 125556 | 0.000613 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.13 | 565 | 494 | 1.14 | 0.0000340 | 4898 |
Missense in Polyphen | 201 | 180.51 | 1.1135 | 1812 | ||
Synonymous | -2.30 | 273 | 229 | 1.19 | 0.0000176 | 1639 |
Loss of Function | 2.00 | 20 | 32.3 | 0.620 | 0.00000156 | 330 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000817 | 0.000805 |
Ashkenazi Jewish | 0.000100 | 0.0000994 |
East Asian | 0.00104 | 0.00103 |
Finnish | 0.00108 | 0.00102 |
European (Non-Finnish) | 0.000453 | 0.000423 |
Middle Eastern | 0.00104 | 0.00103 |
South Asian | 0.00151 | 0.00134 |
Other | 0.000329 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the lipid remodeling steps of GPI-anchor maturation. Lipid remodeling steps consist in the generation of 2 saturated fatty chains at the sn-2 position of GPI-anchor proteins (GPI-AP). Has phospholipase A2 activity that removes an acyl-chain at the sn-2 position of GPI-anchors during the remodeling of GPI. Required for the shedding of the GPI-AP TDGF1, but not CFC1, at the cell surface. Shedding of TDGF1 modulates Nodal signaling by allowing soluble TDGF1 to act as a Nodal coreceptor on other cells (PubMed:27881714). Also indirectly involved in the translocation of RAC1 from the cytosol to the plasma membrane by maintaining the steady state amount of CAV1-enriched plasma membrane subdomains, stabilizing RAC1 at the plasma membrane (PubMed:27835684). In contrast to myomaker (TMEM8C), has no fusogenic activity (PubMed:26858401). {ECO:0000269|PubMed:26858401, ECO:0000269|PubMed:27835684, ECO:0000269|PubMed:27881714}.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.807
- rvis_EVS
- 0.12
- rvis_percentile_EVS
- 62.4
Haploinsufficiency Scores
- pHI
- 0.174
- hipred
- N
- hipred_score
- 0.383
- ghis
- 0.476
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.176
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tmem8
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Gene ontology
- Biological process
- biological_process
- Cellular component
- lysosomal membrane;plasma membrane;integral component of plasma membrane;extracellular exosome
- Molecular function
- molecular_function;phospholipase A2 activity;protein binding;phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine);phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)